Company profile
Employees
Incorporated
Location
Fiscal year end
SEC CIK
Latest filings (excl ownership)
D/A
Indefinite amount in Convertible promissory notes, sold $9.45M, 15 investors
7 Jun 21
D/A
Indefinite amount in Convertible promissory notes, sold $6.45M, 14 investors
8 Apr 21
D
Indefinite amount in Convertible promissory notes, sold $2.05M, 5 investors
4 Jan 21
D
$79.95M in equity, sold $56.9M, 52 investors
17 Apr 20
D
$53.08M in equity, sold $53.08M, 71 investors
6 Jul 18
D
$3M in equity, sold $2.51M
6 Dec 17
Latest ownership filings
SC 13D/A
AgeX Therapeutics, Inc.
26 Mar 24
SC 13D/A
AgeX Therapeutics, Inc.
7 Mar 24
SC 13D/A
AgeX Therapeutics, Inc.
14 Feb 24
SC 13D/A
AgeX Therapeutics, Inc.
5 Feb 24
SC 13D/A
AgeX Therapeutics, Inc.
17 Jan 24
SC 13D/A
AgeX Therapeutics, Inc.
9 Jan 24
SC 13D/A
AgeX Therapeutics, Inc.
13 Dec 23
SC 13D/A
AgeX Therapeutics, Inc.
16 Nov 23
SC 13D/A
AgeX Therapeutics, Inc.
1 Nov 23
SC 13D/A
AgeX Therapeutics, Inc.
24 Aug 23
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
25 Apr 23 | Juvenescence | Warrant to Purchase Common Stock Common Stock | Grant | Acquire A | No | No | 0.661 | 756,429 | 500.00 k | 756,429 |
14 Mar 23 | Juvenescence | Common Stock | Gift | Dispose G | No | No | 0 | 16,447,500 | 0.00 | 0 |
16 Feb 23 | Juvenescence | Warrant to Purchase Common Stock Common Stock | Grant | Acquire A | No | No | 0.6235 | 801,924 | 500.00 k | 801,924 |
7 Feb 23 | Juvenescence | Warrant to Purchase Common Stock Common Stock | Grant | Acquire A | No | No | 0.735 | 340,136 | 250.00 k | 340,136 |
19 Dec 22 | Juvenescence | Warrant to Purchase Common Stock Common Stock | Grant | Acquire A | No | No | 0.59 | 847,457 | 500.00 k | 847,457 |